Emory Healthcare Rounds: Recent Episodes
Emory Healthcare
Yazan Duwayri, MD and Bradley G Leshnower, MD join the podcast in this panel discussion about the Emory Aortic Center, and how it brings together the experience, expertise and passion of Emory’s cardiac and vascular surgeons to offer the latest endovascular options.
Martha Arellano, MD, discusses the challenges and uncertainties for older patients with Acute Myeloid Leukemia, treatment options available, ongoing research and when it is important to refer to the specialists at Winship Cancer Institute of Emory University.
The Emory Proton Therapy Center will be the first center of its kind in Georgia to offer patients access to this new, state-of-the-art radiation therapy. Staffed with physicians and other medical professionals from Winship Cancer Institute and Emory Healthcare who have the necessary expertise in radiation oncology and proton therapy to operate a world-class facility.
Mark McDonald, MD, discusses Proton therapy vs Photon Therapy and the ways in which Winship’s unique position helps to lead cutting edge research and clinical trials in Proton Therapy as an advanced treatment modality.
Each year, nearly 70,000 adolescents and young adults (AYA) are diagnosed with cancer. Lymphoma is the most common type of blood cancer and accounts for nearly 1-in-5 cancer diagnoses among young people.
Survivors of cancers that occurred during adolescence and young adulthood (AYA) are confronted with the dual demands of managing their transition to independent adulthood, concurrently with their transition from cancer patient to cancer survivors.
Kristie A. Blum, MD, discusses the management of adolescents and young adults with cancer and the special challenges these brave young patients face.
The Emory Proton Therapy Center will be the first center of its kind in Georgia to offer patients access to this new, state-of-the-art radiation therapy. Staffed with physicians and other medical professionals from Winship Cancer Institute and Emory Healthcare who have the necessary expertise in radiation oncology and proton therapy to operate a world-class facility.
Bree Eaton, MD, discusses proton therapy and when to refer to the specialists at The Emory Proton Therapy Center.
According to the National Cancer Institute, the foundations of cancer treatment have typically been surgery, chemotherapy, and radiation therapy, Now however, immunotherapy has become what many in the cancer community now call the “fifth pillar” of cancer treatment.
In this podcast, Gregory B. Lesinski, PhD, MPH, and Bassel El-Rayes, MD , discuss the exciting world of immunotherapy, the breakthroughs that are being discovered at Winship Cancer Institute of Emory University, and when to refer to a specialist.
This is part 2 of our series on the latest advances in immunotherapy.
In this podcast, Gregory B. Lesinski, PhD, MPH, and Bassel El-Rayes, MD , discuss the exciting world of immunotherapy, the breakthroughs that are being discovered at Winship Cancer Institute of Emory University, and when to refer to a specialist.
Lymphoma patients want to know their getting the full range of treatment options and the most current, targeted therapies available. Winship is a leader in translating research breakthroughs into effective therapies for lymphoma patients and can offer an individualized care plan that incorporates the best treatments available.
In this segment Jonathon B. Cohen, MD, Medical Director of Infusion Services at Winship Cancer Institute of Emory University, discusses the next steps for lymphoma and chimeric antigen receptor (CAR) T-Cell Therapy and when to refer to a specialist.